A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2011
12/15/2011	US20110305632 Process for the preparation of asymmetrical bis(thiosemicarbazones)
12/15/2011	US20110303573 Omega 3 fatty acid formulations
12/15/2011	DE102010030053A1 Injizierbare Darreichungsform von Flupirtin Injectable dosage form of flupirtine
12/15/2011	DE102010026883A1 Transdermal system useful e.g. for indication of breast cancer with progesterone-receptor positive status, comprises e.g. aromatase inhibitor, active substance puller protection layer, active substance reservoir
12/15/2011	DE102010023828A1 Pharmazeutisches Präparat, welches Entacapon, Levodopa und Carbidopa enthält A pharmaceutical preparation containing entacapone, levodopa and carbidopa
12/15/2011	DE102010023626A1 Verwendung von Corrinoiden zur arzneilichen Anwendung bei Fell- und Hauterkrankungen bei Klein- und Groß-Tieren (warm- und kaltblütig), (zB bei Fischen, Vögeln, Pferden, Rindern, Kamelen, Hunden, Katzen, Reptilien) Use of corrinoids to drug application for coat and skin diseases in small and large animals (hot- and cold-blooded), (eg fish, birds, horses, cattle, camels, dogs, cats, reptiles)
12/15/2011	DE102010023324A1 Verwendung von Corrinoiden zur kosmetischen Anwendung bei gesundem Fell bzw. gesunder Haut, sowie zur kosmetischen Pflege bei Fell- und Hauterkrankungen bei Klein- und Groß-Tieren (warm- und kaltblütig), (zB bei Fischen, Vögeln, Pferden, Rindern, Kamelen, Hunden Katzen, Reptilien) Use of corrinoids for cosmetic use in healthy coat and healthy skin, and for cosmetic care for coat and skin diseases in small and large animals (hot- and cold-blooded), (eg fish, birds, horses, cattle, camels, dogs cats, reptiles)
12/15/2011	DE102010001332A1 Producing medicament comprises imaging amplified genome segments in isolated tumor sample, reproducing and sequencing fusion area of fused amplified genome segments in amplicons and providing sample, which specifically bind to fusion area
12/15/2011	DE102009041242A1 New heterocyclically substituted aryl compounds are hypoxia-inducible factor inhibitors useful to treat and/or prevent e.g. cancer or tumor diseases, ischemic cardiovascular diseases, heart attack, arrhythmia, stroke, and psoriasis
12/15/2011	CA2838493A1 Applications of partially and fully sulfated hyaluronan
12/15/2011	CA2810162A1 Antimicrobial agents
12/15/2011	CA2802484A1 Methods of treating hematological disorders with quinazolinone compounds in selected patients
12/15/2011	CA2802362A1 Pharmaceutical compositions
12/15/2011	CA2802279A1 Benzamide derivatives and their use as hsp90 inhibtors
12/15/2011	CA2802214A1 Intravaginal administration of misoprostol
12/15/2011	CA2802180A1 Solid compositions
12/15/2011	CA2802154A1 A method for preparation of highly pure asiaticoside composition from centella asiatica and a method of use thereof
12/15/2011	CA2802130A1 Cyanoquinoline derivatives
12/15/2011	CA2802127A1 New use of icariin and epimedium flavonoids containing icariin
12/15/2011	CA2802125A1 Composition containing iridoids and uses thereof
12/15/2011	CA2802107A1 Compounds for treatment of bovine mastitis
12/15/2011	CA2802093A1 Combination therapy with lisdexamphetamine and extended release guanfacine
12/15/2011	CA2802067A1 Inhibitors of hcv ns5a protein
12/15/2011	CA2802064A1 Crystalline forms of kinase inhibitors
12/15/2011	CA2802047A1 Oral spray formulations and methods for administration of sildenafil
12/15/2011	CA2802042A1 Crystalline forms of kinase inhibitors
12/15/2011	CA2802029A1 Crystalline forms of kinase inhibitors
12/15/2011	CA2802021A1 Solid dispersions containing kinase inhibitors
12/15/2011	CA2802010A1 Urea derivatives and their therapeutic use in the treatment of, inter alia, diseases of the respiratory tract
12/15/2011	CA2802005A1 Compositions comprising buprenorphine
12/15/2011	CA2801982A1 Process for the preparation of oil in water emulsions
12/15/2011	CA2801939A1 Pyrrolyl substituted dihydroindol-2-one derivatives, preparation methods and uses thereof
12/15/2011	CA2801909A1 Cyclohexyl-azetidinyl antagonists of ccr2
12/15/2011	CA2801896A1 Oral veterinarian composition for salmonids comprising 1-beta-d-ribofur anosyl-1h-1,2,4-triazole-3-carboxamide and use thereof in the treatment of infectious anemia in salmonids
12/15/2011	CA2801891A1 Combination therapy methods for treating proliferative diseases
12/15/2011	CA2801844A1 Use of 1-beta-d-ribofuranosyl-1h-1,2,4-triazole-3-carboxamide for the treatment of infectious salmon anemia
12/15/2011	CA2801822A1 Agomelatine intermediates and preparation method thereof
12/15/2011	CA2801778A1 Furanyl compounds and the use thereof
12/15/2011	CA2801713A1 Process for extracting materials from biological material
12/15/2011	CA2801676A1 Compositions
12/15/2011	CA2801631A1 Pharmaceutical composition comprising amide derivative or pharmaceutically acceptable salt thereof
12/15/2011	CA2801584A1 Macrocyclic hepatitis c serine protease inhibitors
12/15/2011	CA2801415A1 Trkb agonists and methods of use
12/15/2011	CA2801336A1 Cysteamine derivatives and their use in the treatment of nash
12/15/2011	CA2801275A1 New low molecular weight complexes between iron and maltobionic acid, use thereof for intramuscular or subcutaneous administration in the treatment of anemic states, and new pharmaceutical compositions adapted for these uses
12/15/2011	CA2800673A1 Estrogen receptor modulators and uses thereof
12/15/2011	CA2800670A1 Topical antiviral formulations for prevention of transmission of hsv-2
12/15/2011	CA2800428A1 Treatment of type 2 diabetes
12/15/2011	CA2800426A1 Diversion-resistant microgranules and microtablets
12/15/2011	CA2800379A1 Crystalline form of benzylbenzene sglt2 inhibitor
12/15/2011	CA2800203A1 Morpholino pyrimidines and their use in therapy
12/15/2011	CA2799640A1 5,6-dihydro-2h-[1,4]oxazin-3-yl-amine derivatives useful as inhibitors of beta-secretase (bace)
12/15/2011	CA2799635A1 5-amino-3,6-dihydro-1h-pyrazin-2-one derivatives useful as inhibitors of beta-secretase (bace)
12/15/2011	CA2799634A1 Novel antifungal 5,6-dihydro-4-[(difluoroethyl)phenyl]-4h-pyrrolo[1,2-.alpha.][1,4]benzodiazepine and 4-(difluoroethyl)phenyl-6h-pyrrolo[1,2-.alpha.][1,4]benzodiazepine derivatives
12/15/2011	CA2799022A1 Nitrogen containing heteroaryl compounds
12/15/2011	CA2798213A1 Anti-inflammatory agents
12/15/2011	CA2798143A1 Compound, synthesis, composition and uses thereof
12/15/2011	CA2798129A1 Anti-inflammatory agents
12/15/2011	CA2743527A1 Use of a combination of an inhibitor of the if current of the sinus node and an inhibitor of the angiotensin converting enzyme for the treatment of heart failure
12/14/2011	EP2395112A1 Methods for predicting and overcoming resistance to chemotherapy in ovarian cancer and for predicting colon cancer occurrence
12/14/2011	EP2395076A1 Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy
12/14/2011	EP2395013A2 Proteins comprising conserved regions of Neisseria meningitidis surface antigen NhhA
12/14/2011	EP2395012A2 Modified siRNA molecules and uses thereof
12/14/2011	EP2395007A1 Fractionated products obtained from gamboge resin, and medical uses of the same
12/14/2011	EP2395006A1 Novel compounds obtained from gamboge resin, and medical uses of the same
12/14/2011	EP2395005A1 Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases
12/14/2011	EP2395004A2 Pyrrolo [2,3-b]pyridine derivatives as protein kinase inhibitors
12/14/2011	EP2395003A1 Pyrazole compounds as sigma receptor inhibitors
12/14/2011	EP2395002A1 Pharmaceutical composition containing a heterocyclic modulator of ATP-binding cassette transporters.
12/14/2011	EP2395001A1 Novel pyrimidine derivatives
12/14/2011	EP2395000A1 Benzimidazole compounds that modulate the activity of CDK, GSK and aurora kinases
12/14/2011	EP2394999A1 Aminopyrazine derivative and medicine
12/14/2011	EP2394998A1 3-(5-Amino-6-oxo-1,6-dihydropyridazin-3-yl)-biphenyl derivatives as PDE4 inhibitors
12/14/2011	EP2394996A1 Phenylimidazole compounds
12/14/2011	EP2394994A1 One-pot process for the synthesis of dalfampridine
12/14/2011	EP2394993A2 Novel 2,6-substituted-3-nitropyridine derivative, method for preparing same, and pharmaceutical composition including same
12/14/2011	EP2394992A2 Substituted piperidine compounds and methods of their use
12/14/2011	EP2394990A1 Indoline derivatives
12/14/2011	EP2394988A1 Substituted acylguanidine derivative
12/14/2011	EP2394987A1 Acylguanidine derivative
12/14/2011	EP2394660A1 Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers
12/14/2011	EP2394659A1 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth
12/14/2011	EP2394653A1 Topical pharmaceutical compositions comprising mometasone furoate
12/14/2011	EP2394651A1 Penciclovir or Famciclovir for the Treatment of Recurrent Genital Herpes With a One-Day Application
12/14/2011	EP2394650A1 Use of resiquimod for the treatment of cutaneous metastases
12/14/2011	EP2394649A1 Pharmaceutical compositions containing pyridyl cyanoguanidines, preparation methods and uses thereof
12/14/2011	EP2394648A1 Pharmaceutical composition for oral administration
12/14/2011	EP2394647A1 Methods of treating neuropathic pain by modulation of glycogenolysis or glycolysis pathways
12/14/2011	EP2394646A1 Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy
12/14/2011	EP2394645A2 Medical use of 5-benzylaminosalicylic acid derivatives or salts thereof
12/14/2011	EP2394644A2 Trimetazidine Formulation With Different Release Profiles
12/14/2011	EP2394643A1 Sustained-release formulations of topiramate
12/14/2011	EP2394642A1 5-ALA ester formulations and use thereof
12/14/2011	EP2394641A1 Pharmaceutical formulations of lornoxicam
12/14/2011	EP2394640A1 Improved liposomal formulations of lipophilic compounds
12/14/2011	EP2394638A1 New Pharmaceutical Combinations
12/14/2011	EP2394637A1 Process for obtaining sterile brinzolamide suspensions
12/14/2011	EP2394634A1 Hesperidin-containing composition
12/14/2011	EP2393836A1 Sam-6 variants, target and methods of use
12/14/2011	EP2393827A1 Novel prodrugs of steroidal cyp17 inhibitors/antiandrogens

1 ... 1437 1438 1439 1440 1441 1442 1443 1444 1445 1446 1447 1448 1449 1450 1451 1452 1453 1454 1455 1456 1457 ... 7860